M&A in the Pharmaceuticals sector in 2017. Prim acquires Anota for €1.23M.

, , , , , , ,
Integral service around a transaction
BY : Diego GutiérrezDecember Thu, 2017

We take a look at the main M&A transactions in the Spanish pharmaceutical sector in 2017. In addition, we analyse the purchase of Anota, specialised in distribution for pharmacies and orthopaedics, by Grupo Prim for €1.23M.

We take a look at the main M&A transactions in the Spanish pharmaceutical sector in 2017. In addition, we analyse the purchase of Anota, specialised in distribution for pharmacies and orthopaedics, by Grupo Prim for €1.23M.

About Anota

Anota is a company dedicated to the design, development, manufacture and distribution of technical aids and sports medicine products in the pharmacy and orthopaedic channel in the area of orthotics, podiatry, therapeutic compliance systems and technical aids.

Founded in 1990 with headquarters in Sabadell and offices in Barcelona and Madrid, the company achieved a turnover of €3.2M last year.


About Prim

Prim is a privately owned Spanish business group listed on the Madrid Stock Exchange since 1985. The Group is a reference in the hospital and orthopaedic supplies market, in physiotherapy, thalassotherapy, thermalism, spa, rehabilitation, geriatrics and technical aids. Its activity is divided into six divisions: Hospitals, Orthopaedics, Orthopaedic Clinics, Physiotherapy and Rehabilitation, Pharma and Spa.

It is the leading supplier of healthcare products and services in the Spanish market, with more than 22,000 references in its product portfolio. The Prim Group closed the last financial year with an increase in turnover of 11%, reaching €110.1M, with a net profit of €11.26M (compared to €10.7M in 2015) and a margin on sales of 10.24%. Its ebitda was €15M, 12.7% higher than in 2016, and its financial debt was also reduced by 24.4% last year, with a volume of €1.6M.

Prim acquires distributor Anota for €1.23m

Prim, a company dedicated to the supply of hospital and orthopaedic devices, has acquired the distribution company for pharmacies and orthopaedics Anota for €1.23m. The transaction will be supplemented by a variable portion that will be subject to the results of the acquired company between 2019 and 2021.

This operation reinforces the Prim Group's presence in this channel, allowing it to continue to make progress in its growth strategy within the healthcare sector, thanks to the complementary nature of the structures of the two companies in operational terms, as well as in terms of their distribution and sales network and their range of products.

Top M&A transactions in the Pharmaceutical sector in 2017

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?